Top Rated Antitrust Litigation Attorney in Philadelphia, PA

The founder of NastLaw LLC, Dianne M. Nast has more than 40 years of experience in complex civil litigation. From her office in Philadelphia, Pennsylvania, she provides representation to plaintiffs in antitrust cases involving pharmaceutical manufacturers, defective drug and medical device litigation, and insurance coverage lawsuits. Ms. Nast has served as lead or co-lead counsel in many class actions.

As an undergraduate, Ms. Nast attended The Pennsylvania State University and received a bachelor's degree magna cum laude. She pursued her legal studies at Rutgers Law School and was awarded her Juris Doctor.  Admitted to practice in Pennsylvania and New Jersey, Ms. Nast is also admitted to practice before the U.S. Courts of Appeals for the 3rd, 5th, 6th, 7th, 8th and 11th Circuits and the Supreme Court of the United States, many Federal District Courts and the Courts of Pennsylvania and New Jersey.

Ms. Nast has been appointed as lead counsel in multiple major lawsuits and has helped to obtain multimillion dollar awards or settlements in most of them. By way of example, in a multidistrict litigation case involving diet drugs, she assisted in obtaining a settlement in excess of $6 billion. In another case involving a pharmaceutical remedy for hemophilia, the defendants settled for approximately $600 million. She was one of settlement counsel in the NFL Concussion Litigation which settled for in excess of $1 billion.  Ms. Nast has been selected for inclusion in The Best Lawyers in America each year since 2003, and has received an AV Preeminent* peer review rating through Martindale-Hubbell.  She has received multiple Lifetime Achievement awards and has been invited to membership in numerous honorary organizations and associations.

An active participant in several legal organizations, including the American Association for Justice and the American Bar Association, Ms. Nast has also served on the board of directors of the Center for Research on Women and Newborn Health. She is frequently asked to give presentations on topics related to her practice area at continuing legal education seminars.

Ms. Nast, as noted above, has been appointed as Lead Counsel or as a member of the Executive Committees in scores of  Antitrust, Products Liability and Consumer cases. Most recently she has been appointed by The Honorable Cynthia Rufe to be Liaison and Co-Lead Counsel for Direct Purchaser Plaintiffs in the Generic Pharmaceuticals Pricing Litigation, MDL 2724 (E.D. Pa.), currently one of the largest antitrust MDLs in the United States.

Other cases where Ms. Nast has been appointed as Lead Counsel or Co-Lead Counsel include the following representative cases: Wellbutrin SR Antitrust Litigation, (SAJ Distributors, Inc., et al v. SmithKline Beecham Corp., Civil Action No. 04-5525 (E.D. Pa.)); Steel Drums Antitrust Litigation, MDL No. 887 (S.D. Ohio); Steel Pails Antitrust Litigation, Master File No. C-1-92-213 (S.D. Ohio);Waste Haulers Antitrust Litigation, Master File No. 87-3717 (E.D. Pa.); Comcast Corp. Set-Top Cable Television Box Antitrust Litigation, MDL No. 2034 (E.D. Pa.); Yaz/Yasmin/Ocella/Gianvi Products Liability Litigation, No. 1307 (Phila. C.C.P. No. 1307); Zoloft (Sertraline Hydrochloride) Products Liability MDL Litigation, Beechnut Consumer Litigation, Master File No. 86-6608 (E.D. Pa.); Augmentin Antitrust Litigation C.A. No. 04-CV-23 (E.D. Va.); Chrysler Motors Corporation Overnight Evaluation Program Litigation, MDL 740 (E.D. Mo.); Chrysler II Litigation, Master File No. 92-424-JPG (S.D. Ill.); Hertz Car Rental Litigation, Civil Action No. 88-0661 (E.D. Pa.); SmithKline Beecham Securities Litigation, (Phil. C.C.P. No. 2562); Nifedipine Antitrust Litigation, MDL No. 1515 (D.D.C.); and Paxil Antitrust Litigation (Nichols et al. v. SmithKline Beecham Corp.), Civil Action No. 00-6222 (E.D. Pa.).